Logo image
Characterization of extended spectrum β-lactamase-producing Klebsiella pneumoniae from Beijing, China
Journal article   Peer reviewed

Characterization of extended spectrum β-lactamase-producing Klebsiella pneumoniae from Beijing, China

Dingxia Shen, Patricia Winokur and Ronald N Jones
International journal of antimicrobial agents, Vol.18(2), pp.185-188
2001
DOI: 10.1016/S0924-8579(01)00351-X
PMID: 11516943

View Online

Abstract

Fourteen clinical isolates of Klebsiella pneumoniae with extended-spectrum β-lactamases (ESBLs) were detected by the double disk synergy test and the Etest ESBL strip. Co-resistances included high MICs for aminoglycosides, fluoroquinolones, tetracyclines, and trimethoprim/sulphamethoxazole. Co-resistance was not observed in five of the 14 strains. These isolates were all genetically distinct as determined by the automated ribotyping method. Isoelectric focusing documented the presence of multiple β-lactamases (one to four per isolate) with pIs ranging from 5.4 to 8.4. The majority of isolates contained β-lactamases with pI values of 7.6 and 8.4 consistent with SHV-type ESBLs and an Amp C enzyme, respectively. Emerging ESBL strains in K. pneumoniae compromise the use of agents such as cefotaxime, ceftriaxone, ceftazidime in China; leading to the expansion of quality infection control practices and formulary management programmes to minimize clonal expansion.
ESBL China Klebsiella pneumoniae

Details

Metrics

Logo image